Alnylam Pharmaceuticals
ALNY
#635
Rank
NZ$54.49 B
Marketcap
$422.50
Share price
-0.80%
Change (1 day)
56.27%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Cost to borrow shares

Latest borrow fee for Alnylam Pharmaceuticals (ALNY) shares on Interactive Brokers: 0.3269% (annualized)

Shares available to borrow: 2500000

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Alnylam Pharmaceuticals (ALNY) - cost to borrow in the last 7 days chart

Alnylam Pharmaceuticals (ALNY) - number of shares available to borrow in the last 7 days

Alnylam Pharmaceuticals (ALNY) - cost to borrow from 2024 to 2023

Alnylam Pharmaceuticals (ALNY) - number of shares available to borrow from 2024 to 2023

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
0.4011%2.5 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.25%3 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.2832%1.8 M๐Ÿ‡บ๐Ÿ‡ธ USA
3.379%1.8 M๐Ÿ‡บ๐Ÿ‡ธ USA
6.3513%0.75 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.2554%1 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
0.4081%2.2 M๐Ÿ‡ซ๐Ÿ‡ท France
0.4081%10 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel